Rare and Undiagnosed Disease Research Biorepository
Launched by MAYO CLINIC · Jan 8, 2021
Trial Information
Current as of November 10, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This Mayo Clinic study, called the Rare and Undiagnosed Disease Research Biorepository (PRaUD), is not testing a treatment. Instead, researchers are collecting DNA and other biological samples (blood, urine, tissue, saliva, etc.) and building a large library of information to learn more about rare and hard-to-diagnose diseases. The goal is to enroll up to 5,000 people over about five years and, over time, use the information to understand disease causes, improve diagnostic techniques, and explore potential new treatments. Some participants may have multi-omics testing (a broad look at genes, proteins, and other molecules) to help with diagnosis or discovery.
Who can participate and what to expect: people of any age and sex with a rare or undiagnosed disease, as well as biological family members who may be invited for genetic evaluation, and even healthy volunteers. To join, you need a Mayo Clinic or other medical ID and to be able to give informed consent. Exclusion criteria include situations that would make study participation hard or being institutionalized. The study will collect samples (primarily blood, with other samples if possible) and may follow your health information through medical records and occasional contact for up to five years. It’s being conducted at Mayo Clinic sites in Arizona, Florida, and Minnesota, and individual data are not shared with outside researchers.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Has Mayo Clinic or other medical health system ID, or another unique identifier
- • Able to provide informed consent
- Must meet one of the following:
- • Individual must have evidence of a rare disease or a suspected genetic disorder as determined by a provider or genetic counselor
- • Biological family member of an enrolled individual
- Exclusion Criteria:
- • Individuals who have situations that would limit compliance with the study requirements
- • Institutionalized (i.e. Federal Medical Prison)
About Mayo Clinic
Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Scottsdale, Arizona, United States
Jacksonville, Florida, United States
Rochester, Minnesota, United States
Patients applied
Trial Officials
Filippo Pinto e Vairo, MD, PhD
Principal Investigator
Mayo Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials